• A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts
• Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
• Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 Infection
• Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic
• Defining the risk of SARS-CoV-2 variants on immune protection
• Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
• Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
• Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication
• Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity
• International Consensus Statement on Obstructive Sleep Apnea
• Is the timing of fixation associated with fracture-related infection among tibial plateau fracture patients with compartment syndrome? A multicenter retrospective cohort study of 729 patients
• Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
• Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018
• Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
• SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3
• SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
• The Human Nose Organoid Respiratory Virus Model: an <em>Ex Vivo</em> Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
• The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
• The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics